EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Angiogenesis and Ovarian Cancer: What Potential Do Different Subtypes of Circulating Endothelial Cells Have for Clinical Application?

Du-Bois Asante, Domenico Tierno, Michael Woode iD, Bruna Scaggiante iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25116283 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Du-Bois Asante und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Forensic Sciences, University of Cape Coast, Cape Coast P.O. Box CCLN 33, Ghana. Hauptthemen laut MEDLINE: Neovascularization, Pathologic, Ovarian Neoplasms, Endothelial Cells, Biomarkers, Tumor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC) remains the most fatal disease of gynaecologic malignant tumours. The neovasculature in the tumour microenvironment principally comprises endothelial cells. Haematogenous cancer metastases are significantly impacted by tumour neovascularisation, which predominantly depends on the tumour-derived endothelial vasculogenesis. There is an urgent need for biomarkers for the diagnosis, prognosis and prediction of drug response. Endothelial cells play a key role in angiogenesis and other forms of tumour vascularisation. Subtypes of circulating endothelial cells may provide interesting non-invasive biomarkers of advanced OC that might have the potential to be included in clinical analysis for patients’ stratification and therapeutic management. In this review, we summarise the reported studies on circulating endothelial subtypes in OC, detailing their isolation methods as well as their potential diagnostic, prognostic, predictive and therapeutic utility for clinical application. We highlight key biomarkers for the identification of circulating endothelial cell subtypes and their targets for therapies and critically point out future challenges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neovascularization, PathologicOvarian NeoplasmsEndothelial CellsBiomarkers, TumorHumansFemaleTumor MicroenvironmentPrognosisAngiogenesis

Stichwörter der Autor:innen

CECsCEPCsCTECsangiogenesiscirculating endothelial cellscirculating endothelial progenitor cellscirculating tumour endothelial cellsovarian cancer

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Biomedical and Forensic Sciences, University of Cape Coast, Cape Coast P.O. Box CCLN 33, Ghana.
  • Department of Medicine, Surgery and Health Sciences, University of Trieste, Strada di Fiume 447, I-34149 Trieste, Italy.
  • Department of Life Sciences, University of Trieste, Via Valerio 28, I-34127 Trieste, Italy.

ORCID-Profile: Michael Woode, Bruna Scaggiante

Zitieren

APA

Asante, D. B., Tierno, D., Woode, M., & Scaggiante, B. (2024). Angiogenesis and Ovarian Cancer: What Potential Do Different Subtypes of Circulating Endothelial Cells Have for Clinical Application?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116283

Vancouver

Asante DB, Tierno D, Woode M, Scaggiante B. Angiogenesis and Ovarian Cancer: What Potential Do Different Subtypes of Circulating Endothelial Cells Have for Clinical Application?. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25116283

BibTeX
@article{Asante2024,
  author = {Asante, Du-Bois and Tierno, Domenico and Woode, Michael and Scaggiante, Bruna},
  title = {Angiogenesis and Ovarian Cancer: What Potential Do Different Subtypes of Circulating Endothelial Cells Have for Clinical Application?},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25116283}
}
Kostenlos starten →